Inutral Spp

Inutral SPP: Short-acting insulin from Yugoslavia

Inutral SPP is a short-acting insulin produced in Yugoslavia. It belongs to the pharmaceutical group of short-acting insulins and is widely used in the treatment of diabetes mellitus. Inutral SPP has the international name "Insulin-BD" and is a product of the company ICN Galenika, one of the leading manufacturers of pharmaceuticals in Yugoslavia.

This drug is available under various synonyms, including "Berlinsulin N Normal U-40", "Berlinsulin N Normal pen", "Biogulin Regular U-100", "Biogulin Regular U-40", "Biosulin N", "Brinsulrapi MK", "Brinsulrapi Ch", "Insulin", "Insulin-M", "Insulin Actrapid", "Insulin Actrapid MK", "Insulin Actrapid MS", "Insulin Iletin II Regular" and others.

Inutral SPP is presented in the dosage form of an injection solution with a concentration of 40 U/ml. It is intended for subcutaneous administration and is used by patients with diabetes to control blood glucose levels.

Short-acting insulins, such as Inutral SPP, are usually used to regulate glucose levels after meals. They help the body use glucose efficiently by controlling blood sugar levels and preventing the occurrence of hyperglycemia (high sugar levels) and hypoglycemia (low sugar levels).

It is important to note that when using Inutral SPP, you must follow your doctor's instructions and regularly monitor your blood glucose levels. Insulin dosage and injection schedule may vary depending on the patient's individual needs and the doctor's recommendations.

In conclusion, Inutral SPP is a short-acting insulin produced in Yugoslavia by the company ICN Galenika. It is an injection solution with a concentration of 40 units/ml and is used to control glucose levels in patients with diabetes mellitus. When using Inutral SPP, you must follow your doctor's recommendations and regularly monitor your blood sugar levels to achieve the optimal treatment effect.